{
  "Variants Include": [
    {
      "Gene": "LRRK2",
      "variants": [
        {
          "HGVS": "NM_198578.4:c.6055G>A",
          "cDNA Change": {
            "transcript": "NM_198578.4",
            "ref": "G",
            "alt": "A",
            "position": "6055"
          },
          "Protein Change": {
            "ref": "G",
            "alt": "S",
            "position": "2019"
          },
          "Description in input context": "G2019S"
        },
        {
          "HGVS": "NM_198578.4:c.5096A>G",
          "cDNA Change": {
            "transcript": "NM_198578.4",
            "ref": "A",
            "alt": "G",
            "position": "5096"
          },
          "Protein Change": {
            "ref": "Y",
            "alt": "C",
            "position": "1699"
          },
          "Description in input context": "Y1699C"
        },
        {
          "HGVS": "NM_198578.4:c.7153G>A",
          "cDNA Change": {
            "transcript": "NM_198578.4",
            "ref": "G",
            "alt": "A",
            "position": "7153"
          },
          "Protein Change": {
            "ref": "G",
            "alt": "R",
            "position": "2385"
          },
          "Description in input context": "G2385R"
        }
      ]
    }
  ],
  "Described Disease": {
    "Described Disease": "Parkinson Disease",
    "MONDO": "MONDO:0005180"
  },
  "Experiment Method": [
    {
      "Assay Method": "Immunohistochemistry",
      "Material used": {
        "Material Source": "Animal Model",
        "Material Name": "Transgenic Drosophila",
        "Description": "Transgenic Drosophila over-expressing human LRRK2 alleles (wild type, G2019S, Y1699C, and G2385R) were used for immunohistochemical analysis of whole-mount adult fly brains."
      },
      "Readout type": "Quantitative",
      "Readout description": [
        {
          "Variant": "NM_198578.4:c.6055G>A",
          "Conclusion": "Abnormal",
          "Molecular Effect": "partial loss-of-function",
          "Result Description": "Significant degeneration of dopaminergic (DA) neurons in PPM clusters 1 and 3 in aged flies (60 days old) expressing G2019S LRRK2 compared to controls."
        },
        {
          "Variant": "NM_198578.4:c.5096A>G",
          "Conclusion": "Abnormal",
          "Molecular Effect": "partial loss-of-function",
          "Result Description": "Significant degeneration of dopaminergic (DA) neurons in PPM clusters 1 and 3 in aged flies (60 days old) expressing Y1699C LRRK2 compared to controls."
        },
        {
          "Variant": "NM_198578.4:c.7153G>A",
          "Conclusion": "Abnormal",
          "Molecular Effect": "partial loss-of-function",
          "Result Description": "Age-dependent degeneration of dopaminergic (DA) neurons in PPM clusters 1 and 3 in aged flies (60 days old) expressing G2385R LRRK2, similar to G2019S."
        }
      ],
      "Biological replicates": {
        "Biological replicates": "Yes",
        "Description": "Multiple flies (n=10) were analyzed for DA neuron counts in different clusters."
      },
      "Technical replicates": {
        "Technical replicates": "N.D.",
        "Description": "Not described in the literature."
      },
      "Basic positive control": {
        "Basic positive control": "Yes",
        "Description": "Wild-type LRRK2-expressing flies were used as a control."
      },
      "Basic negative control": {
        "Basic negative control": "Yes",
        "Description": "Age-matched normal flies were used as controls."
      },
      "Validation controls P/LP": {
        "Validation controls P/LP": "N.D.",
        "Counts": "0"
      },
      "Validation controls B/LB": {
        "Validation controls B/LB": "N.D.",
        "Counts": "0"
      },
      "Statistical analysis method": {
        "Statistical analysis method": "Student's t-test was used for statistical analysis."
      },
      "Threshold for normal readout": {
        "Threshold for normal readout": "No significant loss of DA neurons compared to age-matched controls.",
        "Source": "Custom"
      },
      "Threshold for abnormal readout": {
        "Threshold for abnormal readout": "Significant loss of DA neurons in specific clusters compared to age-matched controls.",
        "Source": "Custom"
      },
      "Approved assay": {
        "Approved assay": "Yes"
      }
    },
    {
      "Assay Method": "Climbing Assay",
      "Material used": {
        "Material Source": "Animal Model",
        "Material Name": "Transgenic Drosophila",
        "Description": "Three groups of 20 female adult flies expressing LRRK2 transgenes under the Ddc-GAL4 driver were used for climbing assays."
      },
      "Readout type": "Quantitative",
      "Readout description": [
        {
          "Variant": "NM_198578.4:c.6055G>A",
          "Conclusion": "Abnormal",
          "Molecular Effect": "partial loss-of-function",
          "Result Description": "Aged flies (60 days old) expressing G2019S LRRK2 recorded dramatically poorer climbing scores (<10% success) compared to controls."
        },
        {
          "Variant": "NM_198578.4:c.5096A>G",
          "Conclusion": "Abnormal",
          "Molecular Effect": "partial loss-of-function",
          "Result Description": "Aged flies (60 days old) expressing Y1699C LRRK2 recorded dramatically poorer climbing scores (<10% success) compared to controls."
        },
        {
          "Variant": "NM_198578.4:c.7153G>A",
          "Conclusion": "Normal",
          "Molecular Effect": "No Effect",
          "Result Description": "Aged flies (60 days old) expressing G2385R LRRK2 did not show significantly compromised climbing ability compared to controls."
        }
      ],
      "Biological replicates": {
        "Biological replicates": "Yes",
        "Description": "Three groups of 20 flies were tested in each experiment."
      },
      "Technical replicates": {
        "Technical replicates": "Yes",
        "Description": "Three trials were performed in each experiment at 15 min intervals."
      },
      "Basic positive control": {
        "Basic positive control": "Yes",
        "Description": "Age-matched normal flies were used as controls."
      },
      "Basic negative control": {
        "Basic negative control": "N.D.",
        "Description": "Not described in the literature."
      },
      "Validation controls P/LP": {
        "Validation controls P/LP": "N.D.",
        "Counts": "0"
      },
      "Validation controls B/LB": {
        "Validation controls B/LB": "N.D.",
        "Counts": "0"
      },
      "Statistical analysis method": {
        "Statistical analysis method": "Results are presented as mean ± SEM of the scores obtained in three independent experiments."
      },
      "Threshold for normal readout": {
        "Threshold for normal readout": "Climbing success rate comparable to control flies.",
        "Source": "Custom"
      },
      "Threshold for abnormal readout": {
        "Threshold for abnormal readout": "Climbing success rate significantly lower than control flies (<10% success).",
        "Source": "Custom"
      },
      "Approved assay": {
        "Approved assay": "Yes"
      }
    },
    {
      "Assay Method": "Rotenone Treatment",
      "Material used": {
        "Material Source": "Animal Model",
        "Material Name": "Transgenic Drosophila",
        "Description": "Flies were fed with cornmeal-agar medium containing 50 µM rotenone immediately after eclosion and during the entire experimental period."
      },
      "Readout type": "Quantitative",
      "Readout description": [
        {
          "Variant": "NM_198578.4:c.6055G>A",
          "Conclusion": "Abnormal",
          "Molecular Effect": "partial loss-of-function",
          "Result Description": "Accelerated loss of DA neurons in PPM 2/3 clusters in rotenone-treated flies expressing G2019S LRRK2 beyond that in controls or untreated flies."
        },
        {
          "Variant": "NM_198578.4:c.5096A>G",
          "Conclusion": "Normal",
          "Molecular Effect": "No Effect",
          "Result Description": "Rotenone treatment did not aggravate the phenotype of Y1699C LRRK2-expressing flies at the end of the 15-day experimental period."
        },
        {
          "Variant": "NM_198578.4:c.7153G>A",
          "Conclusion": "Abnormal",
          "Molecular Effect": "partial loss-of-function",
          "Result Description": "Accelerated loss of DA neurons in PPM 2/3 and PAL clusters in rotenone-treated flies expressing G2385R LRRK2 beyond that in controls or untreated flies."
        }
      ],
      "Biological replicates": {
        "Biological replicates": "Yes",
        "Description": "Multiple flies (n=15) were analyzed for DA neuron counts after rotenone treatment."
      },
      "Technical replicates": {
        "Technical replicates": "N.D.",
        "Description": "Not described in the literature."
      },
      "Basic positive control": {
        "Basic positive control": "Yes",
        "Description": "Wild-type LRRK2-expressing flies were used as a control."
      },
      "Basic negative control": {
        "Basic negative control": "Yes",
        "Description": "Control flies treated with vehicle (DMSO) alone were used."
      },
      "Validation controls P/LP": {
        "Validation controls P/LP": "N.D.",
        "Counts": "0"
      },
      "Validation controls B/LB": {
        "Validation controls B/LB": "N.D.",
        "Counts": "0"
      },
      "Statistical analysis method": {
        "Statistical analysis method": "Student's t-test was used for statistical analysis."
      },
      "Threshold for normal readout": {
        "Threshold for normal readout": "No enhanced DA neurodegeneration compared to control flies.",
        "Source": "Custom"
      },
      "Threshold for abnormal readout": {
        "Threshold for abnormal readout": "Accelerated DA neurodegeneration compared to control flies or untreated flies.",
        "Source": "Custom"
      },
      "Approved assay": {
        "Approved assay": "Yes"
      }
    }
  ]
}